Blog · editorial roadmap
We'll write about clinical evidence, AI architecture choices, and the lived experience of women in midlife — the three pillars below. Published essays haven't shipped yet; this page is the planned roadmap so a reader can decide whether the newsletter is worth their email. Subscribe via the footer to get essays as they land.
Clinical evidence
Pillar · planned essaysHow the menopause-care evidence base is shifting underneath us — new MSCP guidance, HRT reframings, what the literature still gets wrong.
A walk through the misdiagnosis literature, the symptom-overlap patterns that drive it, and how grounding on referenced guidelines compresses the path to MSCP-credentialed care.
The MSCP credential, the position-statement modernization, and what a referral path that respects the society's own directory looks like.
Cardiometabolic considerations, postmenopausal bleeding workups, and the difference between local and systemic therapy.
AI architecture
Pillar · planned essaysHow Pause-Health.ai is actually built — Care Router policy, multi-agent fabric, Data 360 grounding, MCP tools. Public source code, public design choices.
The federation pattern against Salesforce Health Cloud + JupyterHealth FHIR + DBDP biomarkers, why the agent doesn't move PHI, and how the prototype keeps the same shape as the production stack.
Six canonical pathways, deterministic risk-band heuristics, and the LLM as the recommendation engine on top of (not in place of) the policy.
OpenTelemetry-style spans for a clinical decision (intake -> identity -> grounding -> routing), and what an A2A protocol looks like at the boundary.
The find_menopause_providers and get_provider_details tools, why we expose them via Model Context Protocol, and how a clinical agent should use them safely.
Lived experience
Pillar · planned essaysStories from the women navigating perimenopause and menopause, the clinicians supporting them, and the system that often makes both harder than it needs to be.
The hypothesis-led research-design plan from /proposal/insights, translated for a non-investor audience.
Why this is the metric that matters most in the validation cohort, and how a provider organization can measure it today without the Pause platform.
The clinical-design principles behind the Pre-Brief Panel and why the visible dossier is the right answer when the embedded chat's hidden-prechat surface doesn't work.
Subscribe
Use the newsletter signup in the footer (it's a single email field). Cadence will be roughly monthly when the first essays publish; we won't send marketing unrelated to the editorial roadmap above. See /privacy for what happens to your email after you submit it.
